USF Pharma S.A. (manufacturer of unpackaged products and quality control)

Ukraine

All drugs from this manufacturer

  • VIMPAT

    The drug is indicated as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lacosamide 50 mg

    ATC: N03AX18

  • VIMPAT

    The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lacosamide 100 mg

    ATC: N03AX18

  • VIMPAT

    The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lacosamide 150 mg

    ATC: N03AX18

  • VIMPAT®

    The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lacosamide 200 mg

    ATC: N03AX18